Sylvain Lemay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sylvain Lemay has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Alexander Beaulieu‐Shearer
Faculty of Medicine Université Laval Québec Canada
1 shared publicationAlexandra Albert
Department of Rheumatology, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Qc, Canada
1 shared publication- Christian Steinberg
Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada
1 shared publication Claudine Laliberté
Department of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec, QC, Canada
1 shared publicationCéline Dupuis
Department of Cardiology Institut Universitaire de Cardiologie et Pneumologie de Québec Québec Canada
1 shared publicationDavid Birnie
Department of Cardiology, Heart Institute, University of Ottawa, Ottawa, ON, Canada
1 shared publication
Latest Publications
- 14 April 2023
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 39 (7) , 981-984
New Perspective in Cardiac Sarcoidosis: The Potential Role of a Dedicated Clinic and the Importance of Collaboration Among Different Specialties
- 14 April 2023
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 39 (7) , 981-984
New Perspective in Cardiac Sarcoidosis: The Potential Role of a Dedicated Clinic and the Importance of Collaboration Among Different Specialties
- 14 December 2022
- Published by Wiley in Clinical Transplantation
- Vol. 37 (2) , e14869
Clinical and echocardiographic evolution of patients with arrhythmogenic cardiomyopathy before heart transplantation
Background: Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiomyopathy characterized by fibrofatty myocardial replacement, and accurate diagnosis can be challenging. The clinical course of patients expressing a severe phenotype of the disease needing heart transplantation (HTx) is not well described in the literature. Therefore, this study aims to describe the clinical and echocardiographic evolution of patients with ACM necessitating HTx.Methods: We retrospectively studied all patients who underwent HTx in our institution between 1998 and 2019 with a definite diagnosis of ACM according to the explanted heart examination.Results: Ten patients with confirmed ACM underwent HTx. Only four of them had a diagnosis of ACM before HTx. These patients were 28 ± 15 years old at the time of their first symptoms. Patients received a diagnosis of heart failure (HF) after 5.9 ± 8.7 years of symptom evolution. The mean age at transplantation was 40 ± 17 years old. All the patients experienced ventricular tachycardia (VT) at least once before their HTx and 50% were resuscitated after sudden death. The mean left ventricular ejection at diagnosis and before transplantation was similar (32% ± 21% vs. 35.0% ± 19.3%, p = NS). Right ventricular dysfunction was present in all patients at the time of transplantation.Conclusion: Patients with ACM necessitating HTx show a high burden of ventricular arrhythmias and frequently present a biventricular involvement phenotype, making early diagnosis challenging. HF symptoms are the most frequent reason leading to the decision to transplant.
- 14 December 2022
- Published by Wiley in Clinical Transplantation
- Vol. 37 (2) , e14869
Clinical and echocardiographic evolution of patients with arrhythmogenic cardiomyopathy before heart transplantation
Background: Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiomyopathy characterized by fibrofatty myocardial replacement, and accurate diagnosis can be challenging. The clinical course of patients expressing a severe phenotype of the disease needing heart transplantation (HTx) is not well described in the literature. Therefore, this study aims to describe the clinical and echocardiographic evolution of patients with ACM necessitating HTx.Methods: We retrospectively studied all patients who underwent HTx in our institution between 1998 and 2019 with a definite diagnosis of ACM according to the explanted heart examination.Results: Ten patients with confirmed ACM underwent HTx. Only four of them had a diagnosis of ACM before HTx. These patients were 28 ± 15 years old at the time of their first symptoms. Patients received a diagnosis of heart failure (HF) after 5.9 ± 8.7 years of symptom evolution. The mean age at transplantation was 40 ± 17 years old. All the patients experienced ventricular tachycardia (VT) at least once before their HTx and 50% were resuscitated after sudden death. The mean left ventricular ejection at diagnosis and before transplantation was similar (32% ± 21% vs. 35.0% ± 19.3%, p = NS). Right ventricular dysfunction was present in all patients at the time of transplantation.Conclusion: Patients with ACM necessitating HTx show a high burden of ventricular arrhythmias and frequently present a biventricular involvement phenotype, making early diagnosis challenging. HF symptoms are the most frequent reason leading to the decision to transplant.